AstraZeneca Reports Calquence SNDA Granted Priority Review in U.S.
Top Gap Ups and Downs on Friday: AZN, NEE, AMT and More
European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading
Novo Nordisk/AstraZeneca's Manufacturing Partner Thermo Fisher Questioned Over Manufacturing Lapses
Thermo Fisher Plant Making Astra/ Sanofi RSV Drug Reportedly Breached FDA Rules
Express News | Exclusive-Thermo Fisher's Greenville, North Carolina Plant Was Found in Breach of US FDA Regulations, Documents Show
Express News | Exclusive-FDA Says the Thermo Fisher Plant Addressed Concerns About Safety Issues Raised in the Audit
Express News | Exclusive-Sanofi Says FDA Findings Were Addressed, All Beyfortus Doses Were Approved by FDA Before They Were Shipped
Express News | Exclusive-FDA's Most Recent Inspection of Thermo Fisher Plant Found Shortfalls in Manufacturing of AstraZeneca's and Sanofi's Beyfortus Rsv Treatment
Dianthus Started at Outperform by Oppenheimer on DNTH103 Opportunity
AstraZeneca Supplemental NDA for Calquence Accepted by FDA
U.S. Tweaks 2025 Medicare Price Negotiation Process
Owkin and AstraZeneca to Develop AI Tool for Breast Cancer Testing
Express News | The FDA Has Accepted And Granted Priority Review AstraZeneca's Supplemental New Drug Application For Calquence (Acalabrutinib) For Previously Untreated Mantle Cell Lymphoma, The FDA Action Date Is Anticipated During Q1 Of 2025
AstraZeneca's Lymphoma Drug Application Secures Priority Review Status in US
AstraZeneca (AZN) Receives a Hold From Jefferies
Express News | AstraZeneca : Jefferies Raises Target Price to $75.5 From $74
Arcus Biosciences, AstraZeneca Collaborate on Developing Carcinoma Treatment
Express News | Arcus Biosciences Inc - AstraZeneca to Sponsor Study on Casdatifan and Volrustomig Combination
AstraZeneca: Strong Sales and Robust Pipeline Underpin Buy Rating